Health
NHS secures world’s most expensive drug to treat babies with rare muscle disease – The Irish News
Patients will be able to access Zolgensma, a one-time gene therapy, said NHS England.

Up to 80 babies a year born with a rare muscle-wasting disease could receive life-changing treatment after the most expensive drug in the world was licensed for use on the NHS in England.
Infants born with Spinal Muscular Atrophy (SMA), an often fatal condition which affects the spinal cord nerves causing paralysis, will be able to access Zolgensma, a one-time gene therapy, said NHS England.
The drug, which replicates a missing gene and restores nerve and muscle function, has a reported list price…
-
General17 hours ago
Byford rail extension opening marks final stage of Perth Metronet
-
Noosa News22 hours ago
Fatal traffic crash, Baringa – Sunshine Coast
-
General18 hours ago
Mango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News14 hours ago
Serious traffic crash, Noosa – Sunshine Coast